ProfileGDS5822 / ILMN_2601823
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 79% 80% 76% 80% 79% 81% 80% 77% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1124.779
GSM1276600PDAC Late Ablation Control 2146.380
GSM1276601PDAC Late Ablation Control 3129.876
GSM1276602PDAC Late Ablation 114180
GSM1276603PDAC Late Ablation 2135.479
GSM1276604PDAC Late Ablation 3169.881
GSM1303940PDAC Late Ablation_anti-CTLA4 1135.380
GSM1303941PDAC Late Ablation_anti-CTLA4 2131.677
GSM1303942PDAC Late Ablation_anti-CTLA4 3108.175